Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thiamine Supplementation in Patients With Septic Shock: A Randomized, Double Blind, Placebo Controlled Trial

NCT03122678 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03122678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03122678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thiamine Supplementation in Patients With Septic Shock: A Randomized, Double Blind, Placebo Controlled Trial
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Withdrawn
Start date
November 5, 2016
Completion date
March 14, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lactic acidosis, septic shock, shock, septic, thiamine deficiency